Page last updated: 2024-08-24

triciribine and Carcinoma, Pancreatic Ductal

triciribine has been researched along with Carcinoma, Pancreatic Ductal in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Deng, M; Evans, D; Fang, Y; Gao, B; Kim, J; Lee, S; Liu, T; Lou, W; Lou, Z; Niu, N; Qin, B; Wang, L; Xie, F; Yu, J; Zhang, H	1

Other Studies

1 other study(ies) available for triciribine and Carcinoma, Pancreatic Ductal

Article	Year
HEATR1 Negatively Regulates Akt to Help Sensitize Pancreatic Cancer Cells to Chemotherapy. Cancer research, 2016, Feb-01, Volume: 76, Issue:3 Topics: Animals; Apoptosis; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Cell Proliferation; Deoxycytidine; Down-Regulation; Drug Resistance, Neoplasm; Female; Gemcitabine; Humans; Mice, Nude; Minor Histocompatibility Antigens; Oncogene Protein v-akt; Pancreatic Neoplasms; Phosphorylation; Random Allocation; Ribonucleosides; RNA-Binding Proteins; Xenograft Model Antitumor Assays	2016

Article

Year

HEATR1 Negatively Regulates Akt to Help Sensitize Pancreatic Cancer Cells to Chemotherapy.

Cancer research, 2016, Feb-01, Volume: 76, Issue:3

Topics: Animals; Apoptosis; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Cell Proliferation; Deoxycytidine; Down-Regulation; Drug Resistance, Neoplasm; Female; Gemcitabine; Humans; Mice, Nude; Minor Histocompatibility Antigens; Oncogene Protein v-akt; Pancreatic Neoplasms; Phosphorylation; Random Allocation; Ribonucleosides; RNA-Binding Proteins; Xenograft Model Antitumor Assays

2016